Delay induced stability switch in a mathematical model of CD8 T-cell response to SARS-CoV-2 mediated by receptor ACE2.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Lv J;Lv J; Ma W; Ma W
  • Source:
    Chaos (Woodbury, N.Y.) [Chaos] 2024 Apr 01; Vol. 34 (4).
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: American Institute of Physics Country of Publication: United States NLM ID: 100971574 Publication Model: Print Cited Medium: Internet ISSN: 1089-7682 (Electronic) Linking ISSN: 10541500 NLM ISO Abbreviation: Chaos Subsets: MEDLINE
    • Publication Information:
      Publication: Melville, NY : American Institute of Physics
      Original Publication: Woodbury, NY : American Institute of Physics, 1991-
    • Subject Terms:
    • Abstract:
      The pathogen SARS-CoV-2 binds to the receptor angiotensin-converting enzyme 2 (ACE2) of the target cells and then replicates itself through the host, eventually releasing free virus particles. After infection, the CD8 T-cell response is triggered and appears to play a critical role in the defense against virus infections. Infected cells and their activated CD8 T-cells can cause tissue damage. Here, we established a mathematical model of within-host SARS-CoV-2 infection that incorporates the receptor ACE2, the CD8 T-cell response, and the damaged tissues. According to this model, we can get the basic reproduction number R0 and the immune reproduction number R1. We provide the theoretical proof for the stability of the disease-free equilibrium, immune-inactivated equilibrium, and immune-activated equilibrium. Finally, our numerical simulations show that the time delay in CD8 T-cell production can induce complex dynamics such as stability switching. These results provide insights into the mechanisms of SARS-CoV-2 infection and may help in the development of effective drugs against COVID-19.
      (© 2024 Author(s). Published under an exclusive license by AIP Publishing.)
    • Accession Number:
      EC 3.4.17.23 (Angiotensin-Converting Enzyme 2)
    • Publication Date:
      Date Created: 20240412 Date Completed: 20240415 Latest Revision: 20240415
    • Publication Date:
      20240415
    • Accession Number:
      10.1063/5.0187872
    • Accession Number:
      38608314